Anavex Life Sciences (AVXL) - 2019 Q3 - Quarterly Report
Anavex Life Sciences (AVXL)2019-08-07 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | --- | --- | --- | |---------------------------------------|------------------|-----------------------------------------------------| | Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | | Common Stock Par Value $0.001 | AVXL | NASDAQ Stock Market LLC | FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2 ...